Abstract

Objectives: Smith-Lemli-Opitz syndrome (SLOS) is a rare inherited disease caused by the gene mutation of 7-dehydrocholesterol (7DHC) reductase catalyzing the last step of cholesterol biosynthesis. High oxidizability of 7DHC and the appearance of small-sized low-density lipoprotein (LDL) subfractions may indicate an increased endogenous oxidative stress. In turn, high-density lipoprotein (HDL)-linked paraoxonase-1 (PON1) enzyme prevents lipoproteins from oxidative modifications. Our aim was to determine PON1 activity and the distribution of lipoprotein subfractions in SLOS.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call